Search filters

List of works by Marc S Raab

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

scientific article published in January 2019

A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma

scientific article published on 20 March 2015

A systematic classification of death causes in multiple myeloma.

scientific article published on 8 March 2018

Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma.

scientific article published on 21 January 2015

Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

scientific article published on 29 June 2018

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

scientific article published on 20 July 2020

Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

scientific article published on 27 August 2019

Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma

scientific article published on 11 November 2019

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma

scientific article published on 06 August 2019

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice.

scientific article

Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.

scientific article published on 16 November 2015

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

scientific article published on 01 November 2018

Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016

scientific article published on 22 November 2018

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

scientific article published on 08 June 2018

Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model

scientific article published on 12 March 2020

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

scientific article published on 07 January 2021

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation.

scientific article published on 11 May 2017

Multiple myeloma

scientific article published in The Lancet

Multiple myeloma: patient outcomes in real-world practice

scientific article published on 13 July 2016

Multiple myeloma: practice patterns across Europe

scientific article

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma

scientific article published on 01 August 2019

Oxygen bubbles to predict sensitivity to IMiDs.

scientific article published in February 2017

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

scientific article published on 18 August 2016

Potential therapeutic targets in plasma cell disorders: A flow cytometry study.

scientific article published on 15 December 2015

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.

scientific article

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla

scientific article

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

scientific article published on 07 February 2020

Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

scientific article

Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition.

scientific article published on 16 February 2016

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial.

scientific article published on 3 April 2015

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.

scientific article published on 25 July 2016

Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma

scientific article published on 01 October 2007

Paulina is supported by:

About Paulina

Help